Skip to main content

Allakos Inc.

ALLKDelisted May 15, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001564824

Allakos Inc. was delisted on May 15, 2025; its insiders filed their last Form 4 on May 19, 2025; 64 institutions reported holding it in 13F filings for Q1 2025, worth $14.1M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Allakos Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of ALLK: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders101178−22
Shares75.6M1.27M70.3M−4.09M (−5.5%)
Value$75.6M$1.27M$45.9M−$28.5M (−38.3%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Allakos Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ALLK in Q3 2024
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.1,750,000$1.14M0.00%
BlackRock, Inc.1,272,264$831.0K0.00%
EcoR1 Capital, LLC192,346$125.6K0.00%
Group One Trading, L.P.98,649$64.4K0.00%
Almitas Capital LLC91,301$59.6K0.02%
Two Sigma Investments, LP59,089$38.6K0.00%
Tang Capital Management LLC45,262$29.6K0.00%
XTX Topco Ltd28,867$18.9K0.00%
Avion Wealth733$00.00%

Sold out (31)

Institutions that held Allakos Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held Allakos Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALLK in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.1,267,129$1.27M